Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
Troost JP, Trachtman H, Spino C, Kaskel FJ, Friedman A, Moxey-Mims MM, Fine RN, Gassman JJ, Kopp JB, Walsh L, Wang R, Gipson DS. Troost JP, et al. Among authors: walsh l. Am J Kidney Dis. 2021 Feb;77(2):216-225. doi: 10.1053/j.ajkd.2020.04.014. Epub 2020 Aug 10. Am J Kidney Dis. 2021. PMID: 32791086 Free PMC article. Clinical Trial.
Health-Related Quality of Life in Focal Segmental Glomerular Sclerosis and Minimal Change Disease: A Qualitative Study of Children and Adults to Inform Patient-Reported Outcomes.
Carlozzi NE, Massengill SF, Trachtman H, Walsh L, Singhal N, LaVigne JM, Miner JA, Desmond HE, Lynam C, Gipson DS. Carlozzi NE, et al. Among authors: walsh l. Kidney Med. 2021 Apr 20;3(4):484-497.e1. doi: 10.1016/j.xkme.2021.01.013. eCollection 2021 Jul-Aug. Kidney Med. 2021. PMID: 34401716 Free PMC article.
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.
Walsh L, Reilly JF, Cornwall C, Gaich GA, Gipson DS, Heerspink HJL, Johnson L, Trachtman H, Tuttle KR, Farag YMK, Padmanabhan K, Pan-Zhou XR, Woodworth JR, Czerwiec FS. Walsh L, et al. Kidney Int Rep. 2021 Jul 23;6(10):2575-2584. doi: 10.1016/j.ekir.2021.07.006. eCollection 2021 Oct. Kidney Int Rep. 2021. PMID: 34622097 Free PMC article.
Developing an Edema Clinician-Reported Outcome Measure for Nephrotic Syndrome.
Gipson DS, Pal M, Desmond H, Anderson C, Walsh L, Trachtman H, Massengill SF, Gipson P, Rao PS, Thurman J, Kopp J, Kamil E, Lamothe J, Mariani LH, LaFleur P, Vento S, O'Shaughnessy M, Farag YMK, Simon C, Carlozzi NE. Gipson DS, et al. Among authors: walsh l. Glomerular Dis. 2023 Jun 12;3(1):132-139. doi: 10.1159/000531505. eCollection 2023 Jan-Dec. Glomerular Dis. 2023. PMID: 37901701 Free PMC article.
Proteinuria as an End Point in Clinical Trials of Focal Segmental Glomerulosclerosis.
Mariani LH, Trachtman H, Thompson A, Gillespie BS, Denburg M, Diva U, Geetha D, Greasley PJ, Hladunewich MA, Huizinga RB, Inrig JK, Komers R, Laurin LP, Little DJ, Nachman PH, Smith KA, Walsh L, Gibson KL. Mariani LH, et al. Among authors: walsh l. Am J Kidney Dis. 2024 Oct 23:S0272-6386(24)01038-2. doi: 10.1053/j.ajkd.2024.08.011. Online ahead of print. Am J Kidney Dis. 2024. PMID: 39455047
Synovial innate immune exhaustion is associated with worse pain in knee osteoarthritis.
Philpott HT, Birmingham TB, Blackler G, Klapak JD, Knights AJ, Farrell EC, Fiset B, Walsh LA, Giffin JR, Vasarhelyi EM, MacDonald SJ, Lanting BA, Maerz T, Appleton CT; WOREO Knee Study Group. Philpott HT, et al. Among authors: walsh la. Arthritis Rheumatol. 2024 Dec 17. doi: 10.1002/art.43089. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 39690716
1,219 results